<?xml version="1.0" encoding="UTF-8"?>
<p>The first-eluting 
 <bold>12 b</bold> was obtained as a white solid (98 mg, 17%). Mp.: 178–180 °C. R
 <sub>f</sub>=0.71 (ss A). Anal calcd. for C
 <sub>32</sub>H
 <sub>38</sub>BrN
 <sub>3</sub>O
 <sub>2</sub>: C, 66.66; H, 6.64. Found: 66.73; H, 6.72. 
 <sup>1</sup>H NMR (CDCl
 <sub>3</sub>) 
 <italic>δ</italic> ppm: 1.05 (s, 3H, H-18), 1.31 (s, 9H, 4′-C(CH
 <sub>3</sub>)
 <sub>3</sub>), 2.65 and 3.00 (2 × m, 2 × 1H, H-6), 5.23 (m, 2H, OCH
 <sub>2</sub>), 5.49 (s, 2H, NCH
 <sub>2</sub>), 6.87 (d, 
 <italic>J</italic> = 8.7 Hz, H-2), 7.18 (d, 
 <italic>J</italic> = 8.7 Hz, 1H, H-1), 7.20 (d, 
 <italic>J</italic> = 8.4 Hz, 2H, H-2′, and H-6′), 7.38 (d, 
 <italic>J</italic> = 8.4 Hz, 2H, H-3′, and H-5′), 7.58 (s, 1H, C = CH). 
 <sup>13 </sup>C NMR (CDCl
 <sub>3</sub>) 
 <italic>δ</italic> ppm: 21.0 (CH
 <sub>2</sub>), 25.0 (C-18), 28.3 (CH
 <sub>2</sub>), 28.4 (CH
 <sub>2</sub>), 31.2 (3 C, 4′-C(
 <underline>C</underline>H
 <sub>3</sub>)
 <sub>3</sub>), 31.6 (CH
 <sub>2</sub>), 31.9 (CH
 <sub>2</sub>), 33.4 (CH
 <sub>2</sub>), 34.6 (4′-
 <underline>C</underline>(CH
 <sub>3</sub>)
 <sub>3</sub>), 40.6 (CH), 41.7 (CH), 49.0 (CH), 50.0 (C-13), 53.9 (NCH
 <sub>2</sub>), 63.6 (OCH
 <sub>2</sub>), 111.4 (C-2), 115.2 (C-4), 122.6 (C=
 <underline>C</underline>H), 125.5 (C-1), 126.0 (2 C, C-3′, and C-5′), 127.8 (2 C, C-2′, and C-6′), 131.5 (C-10), 134.9 (C-1′), 137.9 (C-5), 144.6 (
 <underline>C</underline>=CH), 151.9 and 152.6 (2 C, C-3, and C-4′), 221.4 (C-17). MS: [M + H]
 <sup>+</sup> (79/81Br) 575 and 577. Continued elution yielded first a mixture of 
 <bold>12 b</bold> (80 mg, 14%) and 
 <bold>11 b</bold> (140 mg, 24%), and then compound 
 <bold>11 b</bold> (218 mg, 38%) as a white solid. Mp.: 148–150 °C. R
 <sub>f</sub>=0.62 (ss A). Anal calcd. for C
 <sub>32</sub>H
 <sub>38</sub>BrN
 <sub>3</sub>O
 <sub>2</sub>: C, 66.66; H, 6.64. Found: 64.72; H, 6.72. 
 <sup>1</sup>H NMR (CDCl
 <sub>3</sub>) 
 <italic>δ</italic> ppm: 1.05 (s, 3H, H-18), 1.37 (s, 9H, 4′-C(CH
 <sub>3</sub>)
 <sub>3</sub>), 2.70–2.82 (overlapping multiplets 2H, H-6), 5.22 (m, 2H, OCH
 <sub>2</sub>), 5.49 (s, 2H, NCH
 <sub>2</sub>), 6.74 (s, 1H, H-4), 7.20 (d, 
 <italic>J</italic> = 8.4 Hz, 2H, H-2′, and H-6′), 7.37–7.39 (overlapping multiplets, 3H, H-3′, H-5′, and H-1), 7.58 (s, 1H, C = CH). 
 <sup>13 </sup>C NMR (CDCl
 <sub>3</sub>) 
 <italic>δ</italic> ppm: 20.9 (CH
 <sub>2</sub>), 25.0 (C-18), 28.0 (CH
 <sub>2</sub>), 28.2 (CH
 <sub>2</sub>), 30.0 (CH
 <sub>2</sub>), 31.2 (4′-C(
 <underline>C</underline>H
 <sub>3</sub>)
 <sub>3</sub>), 31.9 (CH
 <sub>2</sub>), 33.4 (C), 34.6 (4′-
 <underline>C</underline>(CH
 <sub>3</sub>)
 <sub>3</sub>), 41.1 (CH), 41.3 (CH), 49.1 (CH), 50.0 (C-13), 53.9 (NCH
 <sub>2</sub>), 63.7 (OCH
 <sub>2</sub>), 109.5 (C-2), 114.3 (C-4), 122.6 (C=
 <underline>C</underline>H), 126.0 (2 C, C-3′, and C-5′), 127.8 (2 C, C-2′, and C-6′), 130.7 (C-1), 131.4 (C-10), 134.4 (C-1′), 137.4 (C-5), 144.6 (
 <underline>C</underline>=CH), 151.9 and 152.4 (2 C, C-3, and C-4′), 221.3 (C-17). MS: [M + H]
 <sup>+</sup> (79/81Br) 575 and 577.
</p>
